Novel small-molecule approach to cancer therapy could lead to new treatments
A small molecule has been developed by researchers at the Baylor College of Medicine (Houston, TX, USA) that targets the steroid receptor coactivator family of cancer cell activators, and which could lead to novel anticancer agents.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.